Voloridge Investment Management
CLVS

Voloridge Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Voloridge Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-140,226
Closed -$551K – 1429
2019
Q3 		$551K Buy
140,226
+95,051
+210% +$769K 0.01% 779
2019
Q2 		$672K Buy
+45,175
New +$816K 0.02% 524
2017
Q3 		– Sell
-237,631
Closed -$22.2M – 569
2017
Q2 		$22.2M Sell
237,631
-65,058
-21% -$3.98M 0.55% 44
2017
Q1 		$19.3M Buy
302,689
+118,996
+65% +$7.23M 0.47% 46
2016
Q4 		$8.16M Buy
+183,693
New +$6.47M 0.18% 146
2015
Q4 		– Sell
-67,559
Closed -$6.21M – 339
2015
Q3 		$6.21M Buy
+67,559
New +$5.85M 0.29% 89

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Voloridge Investment Management's CLVS Position: Q4 2019 in Review

Voloridge Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 140,226 shares — an estimated $551K sold.

Voloridge Investment Management first reported a position in CLVS in Q3 2015 and held it in 6 quarters. The position peaked at $22.2M in Q2 2017. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Voloridge Investment Management reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • Voloridge Investment Management sold 140,226 Clovis Oncology, Inc. shares in Q4 2019, an estimated $551K.
  • Voloridge Investment Management first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 6 quarters.
  • Voloridge Investment Management's Clovis Oncology, Inc. position peaked at $22.2M in Q2 2017.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Voloridge Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.